Roche Holding AG Won't Pursue Patent For Breast Cancer Drug In India-Business Standard

Friday, 16 Aug 2013 06:20am EDT 

Business Standard reported that Indian government had 'treated as withdrawn' patent applications by Roche Holding AG for offshoot medicines of its drug 'Herceptin' because the Company did not comply with local norms. The government is looking at a possible issuance of compulsory licence for Roche's Herceptin. The Health Ministry in July submitted to the DIPP all the details of the drug, amid calls to make it affordable. In January, the Health Ministry had approached the DIPP for issuance of compulsory licences (CLs) for three anti-cancer three drugs trastuzumab, ixabepilone and dasatinib which are expensive. 

Company Quote

-0.38 -1.01%
21 Nov 2014